Selective T Cell Costimulation Blocker class drugs
1 result
Nulojix (belatacept)
(BELATACEPT)E.R. Squibb & Sons, L.L.C.
Usage: NULOJIX® (belatacept) is indicated for the prevention of organ rejection in adult kidney transplant recipients. It should be used alongside basiliximab, mycophenolate mofetil, and corticosteroids, but only in EBV seropositive patients. Its efficacy for other transplanted organs is not established.